Question Everything. See who's reporting it.

Morepen launches first US prescription generic, eyes further filings

Source: Business Standard

The story in brief

Morepen Laboratories launched its first US prescription generic, Desloratadine Tablets USP, 5 mg, through its US subsidiary. The company plans further filings and has submitted an ANDA for Sitagliptin Phosphate Tablets. Sanjay Suri, Managing Director, said the move builds on its API relationships and expands into finished-dosage medicines.

NEWXFree on Android and iPhone. Open in NEWX